We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
PPD to Discover Biomarkers for PDL BioPharma
News

PPD to Discover Biomarkers for PDL BioPharma

PPD to Discover Biomarkers for PDL BioPharma
News

PPD to Discover Biomarkers for PDL BioPharma

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "PPD to Discover Biomarkers for PDL BioPharma "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

PPD, Inc. has announced it has signed an agreement by which it will perform comprehensive molecular profiling to discover biomarkers for PDL BioPharma, Inc.

Under the terms of the agreement, PPD's biomarker discovery sciences group will examine specified sample sets utilizing DeepLook™ analysis, its proprietary integrated platform for mass spectrometry-based discovery of biomarkers.

"Identification and implementation of biomarkers can accelerate clinical trials by improving diagnosis, patient selection, and monitoring of disease progression and therapeutic response," said Howard Schulman, vice president of PPD's biomarker discovery sciences.

"We look forward to working with PDL BioPharma to develop biomarkers for its clinical development programs."

Advertisement